A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features

By                      

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 623-636

Spandidos Publications

Access to resources Recommend Favorite

Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer

By Li Min   Liu Wei   Zhu Yan-Fang   Chen Yong-Lin   Zhang Bang-Zhi   Wang Rui  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1115-1119

Informa Healthcare

Access to resources Recommend Favorite

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine

By Saad Everardo   Machado Marcel   Wajsbrot Dalia   Abramoff Roberto   Hoff Paulo   Tabacof Jacques   Katz Artur   Simon Sergio   Gansl René  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 35-41

Humana Press, Inc

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer

By Kondo Naru  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2321-2329

Springer Publishing Company

Access to resources Recommend Favorite